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The aim of this investigation was to study the seasonal variation in the serum levels of eosinophil cationic 
protein (S-ECP). 
The study population comprised a general population sample of 379 individuals (range: 2045 years) 
who were investigated with blood sample for the measurement of S-ECP, skin prick test and 
methacholine challenge. The examination took place between May and October 1991. 
Of the 379 subjects investigated, 137 (36%) were atopic. A significant seasonal variation in S-ECP was 
found in the group of birch-pollen-positive subjects (P<O.O5), but not in the non-atopic or birch-negative 
atopic group. The mean level of S-ECP in birch-positive subjects was about twice as high in June as in 
birch atopic subjects examined during other months. 
It is concluded that seasonal variation in birch-pollen-positive subjects must be taken into account 
when using S-ECP clinically or in epidemiological research. 
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Introduction 
The inflammatory activity of the airways of 
asthmatics can be assessed by means of bron- 
choscopy (1,2), but less invasive methods are 
needed for monitoring airway inflammation 
clinically or in epidemiological studies. Measur- 
ing the serum levels of eosinophil degranulation 
products such as eosinophil cationic protein 
(S-ECP) is thought to be valuable for monitoring 
asthma (3-5). However, the usefulness of periph- 
eral blood markers is dependent on how factors 
other than the disease influence blood levels. The 
purpose of this investigation was to determine 
whether there is seasonal variation in S-ECP. If 
present, this sort of variation should be taken 
into account when using the marker clinically or 
in epidemiologic research. 
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Materials and Methods 
The study population comprised a general 
population sample of 379 individuals from the 
municipality of Uppsala, Sweden [mean age 
(range): 32 (2045) years]. These subjects were 
participants in the European Community Res- 
piratory Health Survey (6). The study was con- 
ducted between April 1991 and February 1992. 
This investigation was limited to subjects who 
were studied in May (n=73), June (n=42), 
August (n=65), September (n= 86) and October 
(n= 114), as the number of subjects examined 
during the other months was low (~40). 
The study included a structured interview, 
skin prick tests, lung function measurements, 
methacholine challenge and blood sampling for 
the measurement of S-ECP. The concentration 
of S-ECP was assayed by means of double 
antibody radioimmunoassay at Pharmacia Diag- 
nostics in Uppsala (5). Atopy was defined as a 
positive prick test (Phazet, Pharmacia Diagnos- 
tics, Uppsala, Sweden) with a mean diameter of 
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2 3 mm. Bronchial hyper-responsiveness (BHR) 
was defined as a fall of 220% in forced expira- 
tory volume in 1 s (FEV,) after the inhalation of 
2 mg or less of methacholine using a dosimeter 
(Mefar, Brescia, Italy) (5,6). 
STATISTICS 
Differences in S-ECP in subjects with and 
without atopy and BHR were analysed using 
unpaired t-test, and the combined effect of these 
variables was studied using multiple linear 
regression. ANOVA was used to analyse sea- 
sonal variation. In order to achieve an approxi- 
mately normal distribution, S-ECP values were 
log transformed. A P value of <O-O5 (two tailed 
test) was regarded as statistically significant. The 
results are presented as mean f SD. 
Results 
Of the 379 subjects investigated, 137 (36%) were 
atopic. Of these, 65 and 72 had positive prick 
tests to birch and timothy, respectively. In 
addition, positive skin prick tests to Dermato- 
phagoides pteronyssinus (n =28), cat (n = 57), 
dog (n=43), mugworth (n=24), Cladopsorium 
hevbatum (n=4) and Alternaria alternata (72~7) 
were found. Levels of S-ECP were significantly 
higher in atopic subjects than in non- 
atopic subjects (15.7 f 9.5 vs. 13.0 f 7.3 pg I- ’ 
(PcO.05). Levels of S-ECP were also sig- 
nificantly higher in the 42 subjects with BHR 
than in those with no BHR (17.1 f 10.8 vs. 
13.6 f 7.9 pg - ‘) (PcO.05). 
When the S-ECP level in the whole population 
was studied, a significant seasonal variation was 
found with a peak mean value in June (PcO.01). 
When comparing atopic and non-atopic sub- 
jects, there was a significant seasonal variation in 
S-ECP in the atopic (P<O.O5) but not in the 
non-atopic group. After further division of the 
atopic individuals into birch-pollen-positive and 
birch-negative subjects, a significant seasonal 
variation in S-ECP in the birch atopic groups 
was found (PcO.05) (Fig. 1). Levels of S-ECP in 
the whole population and in the group of birch- 
pollen-positive subjects remained significantly 
higher in June than in the other months after 
adjusting for BHR using multiple regression 
(P<O*Ol). 
30 
1 
0 
May 
-*- 
JLlIle August September October 
FIG. 1. Seasonal variation in serum eosinophilic 
cationic protein (S-ECP) in non-atopic (7~~242, 
open bars) and atopic subjects with a negative skin 
prick test to birch (n=72, hatched bars), and sub- 
jects with a positive skin prick test to birch (n=65, 
solid bars) (mean and SE). “WO.05. 
In atopic individuals with a positive skin prick 
test to timothy, there was no significant relation- 
ship between the month of investigation and 
S-ECP levels. 
Discussion 
The main finding of this analysis in a general 
population sample was that there was a signifi- 
cant seasonal variation in S-ECP levels. This 
variation was, however, only seen in birch-pollen 
atopic subjects, where the mean level of ECP in 
June was about twice as high as in birch atopic 
subjects examined during any of the other 
months. The correlation between the month 
of investigation and S-ECP remained signi- 
ficant when adjusting for BHR as a possible 
confounder. 
The main birch pollen season in 1991 in the 
Uppsala region started on 28 April and ended on 
31 May. The pollen counts were considerably 
lower than is normally found in the region (mean 
count: l-325 vs. 7.360 birch pollen m - 3, (7). 
Despite this, in accordance with previous 
studies, the present study found seasonal vari- 
ation in S-ECP in birch-pollen atopic subjects, 
with peak levels just after the birch pollen season 
had ended (8,9). The most important new infor- 
mation obtained from this investigation is that 
the magnitude, even during a mild birch pollen 
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season, was sufficient to affect the results for a 
general population. 
No investigations were made during the peak 
of the grass pollen season due to the summer 
holidays in Sweden in July. If S-ECP in grass- 
positive atopics had varied as it did in 
birch-pollen-sensitive subjects, the authors 
would have expected peak levels of S-ECP in 
August. This was not, however, found in the 
present study. 
It is concluded that in northern Europe, 
seasonal variation in birch-pollen-positive sub- 
jects is an additional factor that must be taken 
into account when using S-ECP for the monitor- 
ing of asthma clinically or in epidemiological 
research. 
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